Cannabidiol protects against hepatic ischemia/reperfusion injury by attenuating inflammatory signaling and response, oxidative/nitrative stress, and cell death.
Subject: Liver Disease - PUBLISHED VIA Author Manuscript
Author(s):
Mukhopadhyay P, Rajesh M, Horváth B, Bátkai S, Park O, Tanchian G, Gao RY, Patel V, Wink DA, Liaudet L, Haskó G, Mechoulam R, Pacher P
View Source >>
Related Studies:
Therapeutic potential of cannabidiol against ischemia/reperfusion liver injury in rats.
Published via European Journal of Pharmacology
Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol.
Published via PLOS ONE
The endocannabinoid system and liver diseases.
Published via Journal of Neuroendocrinology
Cannabidiol improves brain and liver function in a fulminant hepatic failure-induced model of hepatic encephalopathy in mice.
Published via British Journal of Pharmacology
Cannabidiol causes activated hepatic stellate cell death through a mechanism of endoplasmic reticulum stress-induced apoptosis.
Published via Cell Death & Disease